Ulcer therapy update.
Brozenec
S A
SA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016481:Helicobacter Infections / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D010353:Patient Education as Topic; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000382:microbiology / Q000451:nursing
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents